Asia Pacific with volume improvement and margin pressure
Compared to the third quarter of 2013, sales by location of customers in Asia Pacific increased by 3 percent to €3.19 billion (Q3, 2013: €3.095 billion). EBIT before special items decreased by €33 million to €173 million (Q3 2013: €206 million).
The increase in sales resulted mainly from volume improvements and an easing of the negative currency effects. Especially Nutrition & Health, Intermediates, Performance Chemicals and Catalysts were able to achieve strong volume growth. From a sub-regional perspective, Korea maintained strong growth, while India, Malaysia and Vietnam started to regain the growth momentum. Volume growth in China slowed down compared to earlier quarters this year.
However, despite some positive developments, our overall performance is still not where it should be. Our volume growth of 5 percent compared to the third quarter of 2013 has to be seen in the light of the projected 2014 growth of the chemical industry in Asia Pacific – which is 6.8 percent! Our growth continues to be far below our strategic target. This requires that we really implement our strategic measures with discipline, vigor and diligence. In particular, we need to improve our profitability in order to contribute to the Group’s overall performance.
Asia Pacific with volume improvement and margin pressure Compared to the third quarter of 2013, sales by location of customers in Asia Pacific increased by 3 percent to €3.19 billion (Q3, 2013: €3.095 billion). EBIT before special items decreased by €33 million to €173 million (Q3 2013: €206 million). The increase in sales resulted mainly from volume improvements and an easing of the negative currency effects. Especially Nutrition & Health, Intermediates, Performance Chemicals and Catalysts were able to achieve strong volume growth. From a sub-regional perspective, Korea maintained strong growth, while India, Malaysia and Vietnam started to regain the growth momentum. Volume growth in China slowed down compared to earlier quarters this year.However, despite some positive developments, our overall performance is still not where it should be. Our volume growth of 5 percent compared to the third quarter of 2013 has to be seen in the light of the projected 2014 growth of the chemical industry in Asia Pacific – which is 6.8 percent! Our growth continues to be far below our strategic target. This requires that we really implement our strategic measures with discipline, vigor and diligence. In particular, we need to improve our profitability in order to contribute to the Group’s overall performance.
การแปล กรุณารอสักครู่..

Asia Pacific with volume improvement and margin pressure
Compared to the third quarter of 2013, sales by location of customers in Asia Pacific increased by 3 percent to €3.19 billion (Q3, 2013: €3.095 billion). EBIT before special items decreased by €33 million to €173 million (Q3 2013: €206 million).
The increase in sales resulted mainly from volume improvements and an easing of the negative currency effects. Especially Nutrition & Health, Intermediates, Performance Chemicals and Catalysts were able to achieve strong volume growth. From a sub-regional perspective, Korea maintained strong growth, while India, Malaysia and Vietnam started to regain the growth momentum. Volume growth in China slowed down compared to earlier quarters this year.
However, despite some positive developments, our overall performance is still not where it should be. Our volume growth of 5 percent compared to the third quarter of 2013 has to be seen in the light of the projected 2014 growth of the chemical industry in Asia Pacific – which is 6.8 percent! Our growth continues to be far below our strategic target. This requires that we really implement our strategic measures with discipline, vigor and diligence. In particular, we need to improve our profitability in order to contribute to the Group’s overall performance.
การแปล กรุณารอสักครู่..
